Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency

Angiogenesis

Volumn 15, Issue 3, 2012, Pages 469-480

  Christoffersson, Gustaf ^a   Zang, Guangxiang ^a   Zhuang, Zhen W ^b   Vågesjö, Evelina ^a   Simons, Michael ^b   Phillipson, Mia ^a   Welsh, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b YALE UNIVERSITY   (United States)

Author keywords

Adherens junctions and permeability; Angiogenesis; Blood flow; Src homology 2 protein B; VE cadherin; VEGF

Indexed keywords

ADAPTOR PROTEIN; MATRIGEL; SRC HOMOLOGY 2 PROTEIN B; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY LIGATION; ARTERY OCCLUSION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL DIAMETER; BLOOD VESSEL PARAMETERS; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TORTUOSITY; CELL JUNCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREMASTER MUSCLE; ENDOTHELIAL DYSFUNCTION; FEMORAL ARTERY; GASTROCNEMIUS MUSCLE; HINDLIMB; IN VIVO STUDY; INTRAVITAL MICROSCOPY; KNOCKOUT MOUSE; LASER DOPPLER FLOWMETRY; MICRO-COMPUTED TOMOGRAPHY; MICROSCOPY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; VENULE; WILD TYPE; X RAY COMPUTED TOMOGRAPHY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; HINDLIMB; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, SCANNING; PROTO-ONCOGENE PROTEINS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MUS;

EID: 84865132846     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9275-z     Document Type: Article

References (37)

1. J Folkman K Watson D Ingber D Hanahan 1989 Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 6219 58 61 10.1038/339058a0 2469964 10.1038/339058a0 1:STN:280:DyaL1M3jvVGntg%3D%3D (Pubitemid 19115892)
2. SM Weis 2008 Vascular permeability in cardiovascular disease and cancer Curr Opin Hematol 15 3 243 249 10.1097/MOH.0b013e3282f97d86 18391792 10.1097/MOH.0b013e3282f97d86 1:CAS:528:DC%2BD1cXltlSnu78%3D (Pubitemid 351509347)
3. AK Olsson A Dimberg J Kreuger L Claesson-Welsh 2006 VEGF receptor signalling-in control of vascular function Nat Rev Mol Cell Biol 7 5 359 371 10.1038/nrm1911 16633338 10.1038/nrm1911 1:CAS:528:DC%2BD28XjslSktrc%3D
4. Matsumoto T, Claesson-Welsh L (2001) VEGF receptor signal transduction. Sci STKE 2001 (112):re21. doi: 10.1126/stke.2001.112.re21
5. Praidou A, Androudi S, Brazitikos P, Karakiulakis G, Papakonstantinou E, Dimitrakos S (2010) Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr Diabetes Rev 6(5):304-312
6. SV Bhadada BR Goyal MM Patel 2011 Angiogenic targets for potential disorders Fundam Clin Pharmacol 25 1 29 47 10.1111/j.1472-8206.2010.00814.x 20199582 10.1111/j.1472-8206.2010.00814.x 1:CAS:528:DC%2BC3MXhslKrsb8%3D
7. M Murakami M Simons 2008 Fibroblast growth factor regulation of neovascularization Curr Opin Hematol 15 3 215 220 10.1097/MOH.0b013e3282f97d98 18391788 10.1097/MOH.0b013e3282f97d98 1:CAS:528:DC%2BD1cXltlSnurk%3D (Pubitemid 351507574)
8. Casey DP, Joyner MJ (2011) Local control of skeletal muscle blood flow during exercise: influence of available oxygen. J Appl Physiol. doi: 10.1152/japplphysiol.00895.2011
9. G Burnstock 2007 Physiology and pathophysiology of purinergic neurotransmission Physiol Rev 87 2 659 797 10.1152/physrev.00043.2006 17429044 10.1152/physrev.00043.2006 1:CAS:528:DC%2BD2sXoslGlsr0%3D (Pubitemid 47084682)
10. D Liu J Krueger F Le Noble 2011 The role of blood flow and microRNAs in blood vessel development Int J Dev Biol 55 4-5 419 429 10.1387/ijdb.103220dl 21858767 10.1387/ijdb.103220dl 1:CAS:528:DC%2BC3MXhsVahs7bI
11. MR Swift BM Weinstein 2009 Arterial-venous specification during development Circ Res 104 5 576 588 10.1161/CIRCRESAHA.108.188805 19286613 10.1161/CIRCRESAHA.108.188805 1:CAS:528:DC%2BD1MXisFeltbc%3D
12. AA Lanahan K Hermans F Claes JS Kerley-Hamilton ZW Zhuang FJ Giordano P Carmeliet M Simons 2010 VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis Dev Cell 18 5 713 724 10.1016/j.devcel.2010.02.016 20434959 10.1016/j.devcel.2010.02.016 1:CAS:528:DC%2BC3cXmvFajt74%3D
13. C Rolny M Mazzone S Tugues D Laoui I Johansson C Coulon ML Squadrito I Segura X Li E Knevels S Costa S Vinckier T Dresselaer P Akerud M De Mol H Salomaki M Phillipson S Wyns E Larsson I Buysschaert J Botling U Himmelreich JA Van Ginderachter M De Palma M Dewerchin L Claesson-Welsh P Carmeliet 2011 HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF Cancer Cell 19 1 31 44 10.1016/j.ccr.2010.11.009 21215706 10.1016/j.ccr.2010.11.009 1:CAS:528:DC%2BC3MXpvValtw%3D%3D
14. P Carmeliet RK Jain 2011 Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases Nat Rev Drug Discov 10 6 417 427 10.1038/nrd3455 21629292 10.1038/nrd3455 1:CAS:528:DC%2BC3MXmvVegurs%3D
15. N Ferrara 2004 Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 4 581 611 10.1210/er.2003-002725/4/581 15294883 10.1210/er.2003-0027 1:CAS:528:DC%2BD2cXns1Ght74%3D (Pubitemid 39099316)
16. S Weis S Shintani A Weber R Kirchmair M Wood A Cravens H McSharry A Iwakura YS Yoon N Himes D Burstein J Doukas R Soll D Losordo D Cheresh 2004 Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction J Clin Invest 113 6 885 894 10.1172/JCI20702 15067321 1:CAS:528:DC%2BD2cXisVagtbg%3D (Pubitemid 38544147)
17. E Dejana E Tournier-Lasserve BM Weinstein 2009 The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications Dev Cell 16 2 209 221 10.1016/j.devcel.2009.01.004 19217423 10.1016/j.devcel.2009.01.004 1:CAS:528:DC%2BD1MXis1aksrw%3D
18. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, Zanetti A, Angellilo A, Mattot V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D, Dejana E (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98(2):147-157 (Pubitemid 29344903)
19. HF Dvorak 2005 Angiogenesis: update 2005 J Thromb Haemost 3 8 1835 1842 10.1111/j.1538-7836.2005.01361.x 16102050 10.1111/j.1538-7836.2005.01361.x 1:CAS:528:DC%2BD2MXpsFKjs7o%3D (Pubitemid 41716570)
20. Baluk P, Hirata A, Thurston G, Fujiwara T, Neal CR, Michel CC, McDonald DM (1997) Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Physiol 272(1 Pt 1):L155-L170
21. F Baffert T Le G Thurston DM McDonald 2006 Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules Am J Physiol Heart Circ Physiol 290 1 H107 H118 10.1152/ajpheart.00542.2005 16126815 10.1152/ajpheart.00542.2005 1:CAS:528:DC%2BD28XhsVKjtb0%3D
22. K Holmqvist MJ Cross C Rolny R Hagerkvist N Rahimi T Matsumoto L Claesson-Welsh M Welsh 2004 The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration J Biol Chem 279 21 22267 22275 10.1074/jbc.M312729200M312729200 15026417 10.1074/jbc.M312729200 1:CAS:528:DC%2BD2cXjvF2rsbk%3D (Pubitemid 38679423)
23. NS Funa V Kriz G Zang G Calounova B Akerblom J Mares E Larsson Y Sun C Betsholtz M Welsh 2009 Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth Cancer Res 69 5 2141 2148 10.1158/0008-5472.CAN-08-3797 19223532 10.1158/0008-5472.CAN-08-3797 1:CAS:528:DC%2BD1MXisFSru70%3D
24. V Kriz J Mares P Wentzel NS Funa G Calounova XQ Zhang K Forsberg-Nilsson M Forsberg M Welsh 2007 Shb null allele is inherited with a transmission ratio distortion and causes reduced viability in utero Dev Dyn 236 9 2485 2492 10.1002/dvdy.21257 17676633 10.1002/dvdy.21257 1:CAS:528:DC%2BD2sXhtFKjurbL (Pubitemid 47450938)
25. L Zagorchev P Oses ZW Zhuang K Moodie MJ Mulligan-Kehoe M Simons T Couffinhal 2010 Micro computed tomography for vascular exploration J Angiogenes Res 2 7 10.1186/2040-2384-2-7 20298533 10.1186/2040-2384-2-7
26. ZW Zhuang L Gao M Murakami JD Pearlman TJ Sackett M Simons ED de Muinck 2006 Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents Radiology 240 3 698 707 10.1148/radiol.2403050976 16926325 10.1148/radiol.2403050976 (Pubitemid 44267325)
27. A Limbourg T Korff LC Napp W Schaper H Drexler FP Limbourg 2009 Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia Nat Protoc 4 12 1737 1746 10.1038/nprot.2009.185 19893509 10.1038/nprot.2009.185 1:CAS:528:DC%2BD1MXhsFKjsr7J
28. M Schnoor FP Lai A Zarbock R Klaver C Polaschegg D Schulte HA Weich JM Oelkers K Rottner D Vestweber 2011 Cortactin deficiency is associated with reduced neutrophil recruitment but increased vascular permeability in vivo J Exp Med 208 8 1721 1735 10.1084/jem.20101920 21788407 10.1084/jem.20101920 1:CAS:528:DC%2BC3MXhtVSit7rK
29. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4(6):915-924 (Pubitemid 30054898)
30. J Gavard JS Gutkind 2006 VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin Nat Cell Biol 8 11 1223 1234 10.1038/ncb1486 17060906 10.1038/ncb1486 1:CAS:528: DC%2BD28XhtFCqu7jP (Pubitemid 44660587)
31. S Mellberg A Dimberg F Bahram M Hayashi E Rennel A Ameur JO Westholm E Larsson P Lindahl MJ Cross L Claesson-Welsh 2009 Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis Faseb J 23 5 1490 1502 10.1096/fj.08-123810 19136612 10.1096/fj.08-123810 1:CAS:528: DC%2BD1MXlsFSms7o%3D
32. AF Nottebaum G Cagna M Winderlich AC Gamp R Linnepe C Polaschegg K Filippova R Lyck B Engelhardt O Kamenyeva MG Bixel S Butz D Vestweber 2008 VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF J Exp Med 205 12 2929 2945 10.1084/jem.20080406 19015309 10.1084/jem.20080406 1:CAS:528:DC%2BD1cXhsVClt7jK
33. MG Lampugnani F Orsenigo MC Gagliani C Tacchetti E Dejana 2006 Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments J Cell Biol 174 4 593 604 10.1083/jcb.200602080 16893970 10.1083/jcb.200602080 1:CAS:528:DC%2BD28XosVKgtL8%3D (Pubitemid 44231870)
34. A Gampel L Moss MC Jones V Brunton JC Norman H Mellor 2006 VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment Blood 108 8 2624 2631 10.1182/blood-2005-12-007484 16638931 10.1182/blood-2005-12-007484 1:CAS:528:DC%2BD28XhtFWgtL7E
35. J Cai L Wu X Qi L Shaw S Li Calzi S Caballero WG Jiang SA Vinores D Antonetti A Ahmed MB Grant ME Boulton 2011 Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability PLoS ONE 6 3 e18076 10.1371/journal.pone.0018076 21464949 10.1371/journal.pone.0018076 1:CAS:528:DC%2BC3MXksVyjsLo%3D
36. Anneren C, Lindholm CK, Kriz V, Welsh M (2003) The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation. Curr Mol Med 3(4):313-324 (Pubitemid 36621789)
37. SS Bhandarkar J Bromberg C Carrillo P Selvakumar RK Sharma BN Perry B Govindarajan L Fried A Sohn K Reddy JL Arbiser 2008 Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo Clin Cancer Res 14 18 5743 5748 10.1158/1078-0432.CCR-08-0405 18794083 10.1158/1078-0432.CCR-08-0405 1:CAS:528:DC%2BD1cXhtFaitrrE